Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
暂无分享,去创建一个
I. Vergote | J. Sehouli | F. Joly | D. Cibula | H. Denys | F. Heitz | R. Largillier | S. Polterauer | E. Petru | F. Selle | J. Lotz | L. Belin | P. Heudel | A. Oaknin | E. Pujade-Lauraine | B. Schmalfeldt | N. de Gregorio | P. Pautier | J. Kurtz | L. Gaba | K. Leitner | O. Rosengarten | C. Lebreton | Manuel Rodrigues | M. Mouret Reynier | C. Churruca | V. D'Hondt | R. Kocián | J. Martinez García | Émilie Bultot-Boissier | Jeronimo Martinez García